News

Vitamin D landscape marked by lack of consensus


 

References

“Curiously, the Sunbelt states of Arizona and Nevada have a high testing rate, in the 8.5%-10.7% range,” said Dr. Millard, a family physician who practices at Seaport Community Health Center in Belfast, Me. “Perhaps it’s because of snowbirds coming down from Canada to get tested. I don’t know. There are certainly lots of retirees in those two states. There are also high levels of testing in Illinois, Maryland, Rhode Island, and Delaware. I don’t have a hypothesis as to why there are variations, but that’s about 10% of all encounters associated with a vitamin D test in those states, which seems like quite a high number.”

The greatest proportion of tests occurred in patients over the age of 65 (39%) years, and about 70% of all vitamin D tests were conducted in females.

Fewer than 0.1% of tests were associated with a diagnosis of osteoporosis. The most common diagnoses associated with ordering of a vitamin D test were depression and falls. “This was particularly true in the elderly group, where falls became much more important, and depression slightly less,” Dr. Millard said. He noted that the EHR findings “don’t answer many questions but clearly the cost for [vitamin D] testing itself is significant. The amount of time my colleagues are spending doing tests and interpreting tests for patients [and] deciding what to do about those results is very considerable. In the long run, the research to resolve these issues may not be anywhere near as expensive as continuing to do what we’re doing now.”

Dr. Rosen and Dr. Millard reporting having no financial disclosures.

dbrunk@frontlinemedcom.com

On Twitter @dougbrunk

Pages

Recommended Reading

Sodium controversy: More fuel for the fire
MDedge Endocrinology
Isolated systolic hypertension linked to angina; isolated diastolic hypertension linked to AAA
MDedge Endocrinology
Modest hypertension control in diabetic patients boosts survival
MDedge Endocrinology
FDA committee gives thumbs-down to hypertension combo
MDedge Endocrinology
FDA should consider cardiovascular polypill – if one is created
MDedge Endocrinology
Fitness attenuates systolic BP’s age-related rise
MDedge Endocrinology
Intensive glycemic control safely cut end-stage renal disease
MDedge Endocrinology
Cigarette smoking rates among U.S. adults hit all-time low
MDedge Endocrinology
New evidence suggests 2014 hypertension guidelines could backfire
MDedge Endocrinology
Obesity can cut 19 years of health, 8 years of life
MDedge Endocrinology